Home
Market Capitalization of Raymed Labs Ltd

Raymed Labs Ltd
NSE: RAYMEDLABS
Market Cap
Key Highlights
- The Market Cap of Raymed Labs Ltd is ₹ 1.23 crore as of 27 Jan 25 .
- The Latest Trading Price of Raymed Labs Ltd is ₹ 2.88 as of 27 Jan 15:30 .

Raymed Labs Ltd
NSE: RAYMEDLABS
Share Price
Market Price of Raymed Labs Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
27 Jan 2025 | 2.88 |
13 Jan 2025 | 2.88 |
23 Dec 2024 | 2.88 |
11 Nov 2024 | 2.75 |
21 Oct 2024 | 2.75 |
23 Sep 2024 | 2.62 |
16 Sep 2024 | 2.62 |
09 Sep 2024 | 2.62 |
29 Jul 2024 | 2.5 |
08 Jul 2024 | 2.5 |
BlinkX Score for Raymed Labs Ltd
Asset Value vs Market Value of Raymed Labs Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Raymed Labs Ltd
Historical P/E Ratio of Raymed Labs Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Raymed Labs Ltd
Historical Revenue of Raymed Labs Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Raymed Labs Ltd
Historical EBITDA of Raymed Labs Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Raymed Labs Ltd
Historical Net Profit of Raymed Labs Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Raymed Labs Ltd
Dividend Payout Over Time
About Raymed Labs Ltd
- Raymed Labs Ltd was established in the year 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities on Dehradun Road, Saharanpur, UP. The Company embarked on a new and exciting phase of its growth journey.
- As a widely operational pharmaceutical company, it proved excellence in the competitive ophthalmology industry with its robust marketing infrastructure across the geographies. Raymed created an integrated multi-technology capability to manufacture all types of formulations with innovative and advanced technologies focusing into Preservative free Ophthalmic dosage specially for Conjunctivitis and Glaucoma Patient care, Various other formulations have been converted from suspension to solution which helps in the effective absorption, penetration and better patience compliance.
Raymed Labs Ltd News Hub
Raymed Labs to convene AGM
Raymed Labs announced that the Annual General Meeting (AGM) of the company will be held on 18 Septem
Read more
17 Aug 24
Raymed Labs to convene AGM
Raymed Labs announced that the Annual General Meeting (AGM) of the company will be held on 18 Septem
Read more
16 Aug 24
Raymed Labs schedules AGM
Raymed Labs announced that the Annual General Meeting (AGM) of the company will be held on 18 Septem
Read more
16 Aug 24
Raymed Labs reports standalone net loss of Rs 0.02 crore in the June 2024 quarter
Net Loss of Raymed Labs reported to Rs 0.02 crore in the quarter ended June 2024 as against net loss
Read more
13 Aug 24